(Q44432205)

2 December 2017

title

Confluent and reticulated papillomatosis: response to tazarotene (English)

1 reference

https://api.crossref.org/works/10.1067/MJD.2003.155

2 December 2017

Confluent and reticulated papillomatosis: Response to tazarotene (English)

1 reference

31 December 2023

1 reference

https://api.crossref.org/works/10.1067/MJD.2003.155

31 December 2023

author name string

Paul H. Bowman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12734485

reference URL

31 December 2023

Loretta S. Davis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12734485

reference URL

31 December 2023

language of work or name

English

0 references

publication date

1 May 2003

1 reference

full work available at URL

2 December 2017

https://api.elsevier.com/content/article/PII:S0190962202615543?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1067/MJD.2003.155

https://api.elsevier.com/content/article/PII:S0190962202615543?httpAccept=text/plain

31 December 2023

1 reference

https://api.crossref.org/works/10.1067/MJD.2003.155

Journal of the American Academy of Dermatology

31 December 2023

published in

1 reference

2 December 2017

volume

48

1 reference

2 December 2017

issue

5 Suppl

1 reference

2 December 2017

page(s)

S80-1

1 reference

Response of psoriasis to a new topical retinoid, AGN 190168

2 December 2017

cites work

https://api.crossref.org/works/10.1067/MJD.2003.155

1

1 reference

Confluent and reticulated papillomatosis of Gougerot and Carteaud. Its relation to other papillomatoses

31 December 2023

https://api.crossref.org/works/10.1067/MJD.2003.155

3

1 reference

Confluent and reticulated papillomatosis: response to high-dose oral isotretinoin therapy and reassessment of epidemiologic data

31 December 2023

https://api.crossref.org/works/10.1067/MJD.2003.155

4

1 reference

Two patients with confluent and reticulated papillomatosis: response to oral isotretinoin and 10% lactic acid lotion

31 December 2023

https://api.crossref.org/works/10.1067/MJD.2003.155

5

1 reference

Confluent and reticulated papillomatosis (Gougerot-Carteaud) treated with tetracyclines

31 December 2023

https://api.crossref.org/works/10.1067/MJD.2003.155

6

1 reference

Ultraviolet light-induced confluent and reticulated papillomatosis

31 December 2023

https://api.crossref.org/works/10.1067/MJD.2003.155

7

1 reference

Clearance of confluent and reticulate papillomatosis of Gougerot and Carteaud with minocycline

31 December 2023

https://api.crossref.org/works/10.1067/MJD.2003.155

9

1 reference

Confluent and reticulated papillomatosis.

31 December 2023

https://api.crossref.org/works/10.1067/MJD.2003.155

10

1 reference

Confluent and reticulated papillomatosis of Gougerot and Carteaud: treatment with selenium sulfide lotion

31 December 2023

https://api.crossref.org/works/10.1067/MJD.2003.155

11

1 reference

Confluent and reticulated papillomatosis: response to minocycline

31 December 2023

https://api.crossref.org/works/10.1067/MJD.2003.155

12

1 reference

Confluent and reticulated papillomatosis: treatment with topical calcipotriol

31 December 2023

https://api.crossref.org/works/10.1067/MJD.2003.155

13

1 reference

Confluent and reticulated papillomatosis: response to isotretinoin

31 December 2023

https://api.crossref.org/works/10.1067/MJD.2003.155

14

1 reference

Confluent and reticulated papillomatosis. Treatment with etretinate

31 December 2023

https://api.crossref.org/works/10.1067/MJD.2003.155

15

1 reference

Confluent and reticulated papillomatosis successfully treated with the aromatic etretinate

31 December 2023

https://api.crossref.org/works/10.1067/MJD.2003.155

16

1 reference

31 December 2023

Identifiers

DOI

10.1067/MJD.2003.155

1 reference

2 December 2017

1 reference